Related Experiment Video
Updated: May 5, 2026

Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
COST action CA22103 Net4Brain: Pan-European network advancing translational research in brain cancer
Terezia Kiskova-Simkova1, Patrik Simko1, Milica Pesic2
1Department of Pathology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovakia.
Abstract:
Brain and central nervous system cancers remain the deadliest forms of cancer, with limited improvement in survival following treatment. The Net4Brain COST Action (CA22103) addresses the urgent need for coordinated and multidisciplinary approaches to understand the pathogenesis, optimize early diagnosis, and personalize treatment strategies. Net4Brain unites a pan-European network of experts in basic and clinical neuroscience, oncology, molecular biology, data science and bioengineering. Through five thematic Working Groups (WGs), innovative Young Researcher´s Group and one dissemination WG, supported by Creative Group, the Action focuses on non-invasive biomarker discovery, preclinical modeling, tumor profiling, computational modeling, and treatment optimization. This initiative supports collaborative research, capacity building, and the development of a shared pan-European brain cancer centralized virtual database and biobank. Progress has been made in standardizing biomarker discovery, building innovative advanced preclinical models, and fostering integration of "omics" and imaging data for clinical applications. Net4Brain overcomes existing fragmentation in brain cancer research by providing a transdisciplinary platform for research and development, innovation, dissemination, and training, ultimately aiming to improve diagnostic accuracy, therapeutic outcomes, and patient quality of life. It also builds critical mass of knowledge/experts in the field of brain cancer and neuro-oncology.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers

